Table 5 Patient characteristics in the motivating example of the International Mission for Prognosis and Analysis of Clinical Trials (IMPACT) dataset with patients grouped based on having received an intracranial pressure monitor
| Ā | Intracranial pressure monitor (nĀ =ā3009) | No intracranial pressure monitor (nĀ =ā4543) |
|---|---|---|
Age (median, IQR) | 34 (23-88) | 27 (20-39) |
Male sex | 2385 (79%) | 3510 (77%) |
GCS motor score (median, IQR) | 4 (2-5) | 4 (2-5) |
Pupillary reactivity | ||
ā-Both pupils reactive | 1822 (61%) | 3130 (69%) |
ā-One pupil reactive | 575 (19%) | 580 (13%) |
ā-No pupil reactive | 612 (20%) | 833 (18%) |
CT classificationb | ||
ā-Normal | 42 (1%) | 373 (8%) |
ā-Diffuse II | 506 (17%) | 62,285 (50%) |
ā-Diffuse III | 473 (16%) | 996 (22%) |
ā-Diffuse IV | 122 (4%) | 180 (4%) |
ā-Mass lesion | 1866 (62%) | 709 (16%) |
tSAH | 1511 (50%) | 1904 (42%) |
GOSa | ||
ā-Death | 832 (28%) | 1666 (37%) |
ā-Persistent vegetative state | 566 (19%) | 977 (22%) |
ā-Severe disability | 559 (19%) | 724 (16%) |
ā-Moderate disability | 161 (5%) | 199 (4%) |
ā-Good recovery | 891 (30%) | 977 (22%) |